Evidence map›Paper›PMID 36548187›Full record

ArticleNeurology international2022

Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil.

Celine Cont, Annaliis Lehto, Nathalie Stute, Anastasia Galli, Christina Schulte, Veronika Deer, Michaela Wessler, Lars Wojtecki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Celine ContDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.
Annaliis LehtoDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.ORCID 0000-0003-3459-8226
Nathalie StuteDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.
Anastasia GalliDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.
Christina SchulteDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.
Veronika DeerDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.
Michaela WesslerDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.
Lars WojteckiDepartment of Neurology and Neurorehabilitation, Hospital zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.ORCID 0000-0002-6205-4405
Hospital zum Heiligen Geist · DEGerman Center for Neurodegenerative Diseases · DE

Funding

Hilde-Ulrichs-Stiftung für Parkinsonforschung to LW
6 · The paper itself

Abstract

So far, deep repetitive transcranial magnetic stimulation (drTMS) has shown promising results as an add-on treatment for Parkinson's disease (PD) but not for non-idiopathic Parkinson Syndromes (PS). We aimed to investigate the safety and feasibility of drTMS application in patients with different Parkinson Syndromes and medical refractory symptoms. Multifaceted real-world data (

Indexed as

adverse device effectadverse eventsdeep transcranial magnetic stimulationParkinson Syndromepatientsreal-world data

Identifiers

PMID36548187
PMCPMC9783590
OpenAlexW4312127825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.